MDL Over Pfizer's Neurontin Soon To Be 46 Cases Lighter

Law360, New York (July 26, 2010, 4:25 PM EDT) -- Lawyers for hundreds of Neurontin multidistrict litigation plaintiffs, who accuse Pfizer Inc. of a fraudulent scheme to promote the anti-epilepsy drug for off-label use, have agreed to cut 46 cases from the proceedings, while missing a key deadline to proceed on behalf of more clients.

The Boone Law Firm PA said in a stipulation lodged Friday in the U.S. District Court for the District of Massachusetts that 33 of its clients had dismissed their claims, and it added in a separate filing that it had not...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.